U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07023705) titled 'MLPR As A Diagnostic Marker For Acute Pulmonary Embolism' on June 09.
Brief Summary: A retrospective study to assess the utility of hematological marker (monocyte to large platelet ratio) to diagnose patients with pulmonary embolism
Study Start Date: Jan. 01, 2024
Study Type: OBSERVATIONAL
Condition:
Pulmonary Embolism (Diagnosis)
Diagnosis
Intervention:
DIAGNOSTIC_TEST: Monocyte to Large Platelet Ratio (MLPR)
Admission laboratory values were used to calculate the Monocyte-to-Large Platelet Ratio (MLPR) by dividing the absolute monocyte count by the large platelet count. These values were obtained from blood samples collected...